Please assess the completion status of the following clinical trial:

Trial Title: PCV13 in Non-pregnant Papua New Guinean Women

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy~* Non-pregnant~* 18-45 years old~Exclusion Criteria:~* Known hypersensitivity to any vaccine component~* Known/suspected to be immunocompromised~* Receipt of corticosteroids ≤30 days before~* Pregnant (pregnancy tests will be performed)~* Not being well at the time of vaccination~* Plan to travel out of the area in the month post-vaccination

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: None

Study Arms:
- Women of childbearing age (Type: None): Healthy non-pregnant women between 18 and 45 years old living in Goroka, Papua New Guinea, will receive one dose of 13-valent pneumococcal conjugate vaccine (PCV).

Based on this trial design, predict the completion outcome and termination type (if applicable).